FDA Adverse Event Injury Summary report: N

ONETOUCHPING GLUCOSEMGMTSYSTEM

MDR report key: 3033252 · Received April 3, 2013

Report

Report Number
2531779-2013-03487
Event Type
Injury
Date Received
April 3, 2013
Report Date
March 7, 2013
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K080639
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE PUMP HAS NOT BEEN REQUESTED FOR RETURN TO ANIMAS. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. THE PATIENT REPORTEDLY PRIMED WHILE ATTACHED AT THE INFUSION SITE. THE PUMP USER GUIDE INSTRUCTS THE PATIENT TO DISCONNECT FROM THE SITE PRIOR TO PERFORMED THE REWIND, LOAD, OR PRIME STEPS. ADDITIONALLY, THE PUMP DISPLAYS A REMINDER MESSAGE INSTRUCTING THE PATIENT TO DISCONNECT FROM THE INFUSION SITE PRIOR TO PERFORMING THE PRIME STEP. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Description of Event or Problem · 1

THE PATIENT CONTACTED ANIMAS ON (B)(6) 2013 REPORTING AN INCIDENT IN WHICH THE PATIENT MAY HAVE INADVERTENTLY PRIMED 180.7 UNITS OF INSULIN WHILE ATTACHED AT THE SKIN SITE. THE PATIENT REPORTED THAT BLOOD GLUCOSE LEVELS DECREASED FROM 222 MG/DL TO 94 MG/DL OVER THE COURSE OF 3 HOURS. THE PATIENT REPORTED TAKING ORAL CARBOHYDRATE AND REPORTED THAT THE BLOOD GLUCOSE WENT AS LOW AS 86 MG/DL BUT DID NOT BELIEVE THAT THE BLOOD GLUCOSE WENT BELOW THAT. THE PATIENT WAS TRANSPORTED TO THE HOSPITAL AND WAS OBSERVED FOR SEVERAL HOURS AND THEN RELEASED. THIS REPORT IS MADE BASED ON THE ALLEGATION THAT THE PATIENT SOUGHT MEDICAL INTERVENTION AFTER PRIMING WHILE ATTACHED TO THE INFUSION SITE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
136025 ONETOUCHPING GLUCOSEMGMTSYSTEM INSULIN INFUSION PUMP LZG ANIMAS CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 58 YR Hospitalization